Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The transforming growth factor-β (TGF-β) signaling pathway is crucial in regulating cancer progression, including metastasis.
• MicroRNAs (miRNAs), small non-coding RNAs, are increasingly recognized for their roles in various cellular processes and diseases, including cancer.
• The interplay between TGF-β signaling and miRNAs is complex and significant in the context of cancer biology.

Purpose of the Study:

• To explore the intricate interactions between miRNAs and the TGF-β pathway in breast cancer (BC) metastasis.
• To elucidate how these interactions modulate key factors involved in the invasion-metastasis cascade.
• To identify potential therapeutic targets for inhibiting BC metastasis.

Main Methods:

• Review and synthesis of existing literature on miRNA-TGF-β interactions in breast cancer metastasis.
• Focus on modulation of invasion-metastasis-related factors: epithelial-to-mesenchymal transition (EMT), cancer stem cells (CSCs), matrix metalloproteinases (MMPs), tissue inhibitors of MMPs (TIMPs), cell adhesion molecules (CAMs), and the tumor microenvironment (TME).

Main Results:

• miRNAs significantly influence TGF-β signaling, impacting multiple facets of breast cancer metastasis.
• Specific miRNAs can either promote or suppress BC cell migration, invasion, angiogenesis, proliferation, and apoptosis by targeting genes within the TGF-β pathway.
• The interaction affects critical metastatic factors such as EMT, CSCs, MMPs, TIMPs, CAMs, and the TME.

Conclusions:

• The complex interplay between miRNAs and the TGF-β pathway is a critical determinant of breast cancer metastasis.
• Targeting the miRNA-TGF-β axis presents a promising avenue for developing novel and safer therapeutic strategies to prevent breast cancer spread.
• Further research into these interactions could lead to significant advancements in breast cancer treatment and management.